Back to Trades
Total Value
$24.8K
Net $24.8K sold
Filing Date
Jul 10, 2026
1 transaction
Sales
$24.8K
1 transaction
Trade Summary
On Jul 8, 2026, Eizen Joshua M, Insider, sold $24.8K of AN2 Therapeutics, Inc. (ANTX) across 1 transaction. The filing covers Common Stock and reflects net selling of $24.8K. Reported prices ranged from $4.17. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- AN2 Therapeutics, Inc.
- Ticker Symbol
- ANTX
- CIK
- 0001880438
Insider Information
- Name
- Eizen Joshua M
- Role
- Insider
- Location
- MENLO PARK, CA
Filing Details
- Filing Date
- Jul 10, 2026
- Transaction Date
- Jul 8, 2026
- Accession Number
- 0001193125-26-301092
- Form Type
- 4
- Net Trading Amount
- -$24.8K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jul 8, 2026 | Common Stock | 5,945 | $4.17 | Sale | $24.8K |
Want live alerts when Eizen Joshua M trades again?
Download Insider Trades to track ANTX, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Represents shares sold pursuant to the terms of the grant to satisfy tax withholding obligations arising from the vesting of Restricted Stock Units ("RSUs") on July 1, 2026.
- (F2)Includes a balance of (a) 30,000 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from January 1, 2024, (b) 31,500 RSUs which vest as follows: 1/4th of the RSUs vest annually over four years from November 4, 2024, (c) 58,500 RSUs which vest as follows 1/4th of the RSUs vest annually over four years from January 1, 2025 and (d) 50,000 RSUs which vest as follows: 1/4th of RSUs vest annually over four years from January 1, 2026, in each case subject to the Reporting Person's continuous service as of such date.
- (F3)Reflects the adjusted total which includes the purchase of 5,000 shares under the Issuer's 2022 Employee Stock Purchase Plan on March 31, 2026.